Literature DB >> 23319903

Manual quantitative assessment of amplitude and sleep stage distribution of excessive fragmentary myoclonus.

Romy Hoque1, David E McCarty, Andrew L Chesson.   

Abstract

INTRODUCTION: Excessive fragmentary myoclonus (EFM) consists of brief, asynchronous, twitch-like movements appearing asymmetrically in sleep. The new AASM Manual for the Scoring of Sleep and Associated Events identifies some EFM scoring criteria but does not provide amplitude criteria for scoring EFM. Older observational series have used 50 μVs. We report data from various amplitude criteria using blinded comparisons.
METHODS: EFMs were analyzed on the polysomnograms of 8 patients (7 men and 1 woman, mean age 57 years, range: 47-79) using a standardized protocol for sensitivity, tonus threshold, impedance, amplitude measurements, and sleep stage. The first 20 minutes each of wake, Stage 1-2, SWS, and REM were analyzed. EFMs ≥ 25, ≥ 40, and ≥ 50 microvolts (μVs) in negative deflection above the baseline were counted in tibialis anterior muscle electromyography (EMG) channels bilaterally.
RESULTS: The mean EFM index per minute for wake, regardless of impedance, was: 7.19 ± 5.90 for ≥ 25 μV amplitude; 2.43 ± 2.02 for ≥ 40 μVs; and 2.08 ± 2.23 for ≥ 50 μVs. For sleep stages, the EFM index by stage and amplitude criteria used for measurements were: Stage 1-2: 7.38 ± 5.79 for ≥ 25 μVs; 3.13 ± 3.33 for ≥ 40 μVs; and 2.36 ± 2.66 for ≥ 50 μVs; SWS: 10.05 ± 8.04 for ≥ 25 μVs; 2.71 ± 3.13 for ≥ 40 μVs; and 1.38 ± 1.92 for ≥ 50 μVs; Total REM: 15.96 ± 11.32 for ≥ 25 μVs; 6.32 ± 4.25 for ≥ 40 μVs; and 3.94 ± 3.73 for ≥ 50 μVs; Phasic REM: 19.69 ± 15.45 for ≥ 25 μVs; 8.63 ± 7.06 for ≥ 40 μVs; and 5.52 ± 6.44 for ≥ 50 μVs; Non-phasic REM: 13.93 ± 11.31 for ≥ 25 μVs; 5.16 ± 3.57 for ≥ 40 μVs; and 3.20 ± 2.92 for ≥ 50 μVs.
CONCLUSION: EFM rates increase with SWS and total REM with the highest EFM rates occurring during phasic REM. EFM rates were increased across all sleep stages when impedance was > 30 KΩ.

Entities:  

Mesh:

Year:  2013        PMID: 23319903      PMCID: PMC3525986          DOI: 10.5664/jcsm.2336

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  8 in total

1.  Excessive fragmentary hypnic myoclonus in a patient affected by a mitochondrial encephalomyopathy.

Authors:  Alessandro Pincherle; Luca Mantoani; Flavio Villani; Paolo Confalonieri; Alessandra Erbetta
Journal:  Sleep Med       Date:  2006-11-13       Impact factor: 3.492

2.  Excessive twitch movements in rapid eye movement sleep with daytime sleepiness.

Authors:  H Mizuma; T Sakamoto
Journal:  Psychiatry Clin Neurosci       Date:  1997-12       Impact factor: 5.188

3.  Excessive fragmentary hypnic myoclonus: clinical and neurophysiological findings.

Authors:  Roberto Vetrugno; Giuseppe Plazzi; Federica Provini; Rocco Liguori; Elio Lugaresi; Pasquale Montagna
Journal:  Sleep Med       Date:  2002-01       Impact factor: 3.492

4.  Excessive fragmentary myoclonus: time of night and sleep stage distributions.

Authors:  O Lins; M Castonguay; W Dunham; S Nevsimalova; R Broughton
Journal:  Can J Neurol Sci       Date:  1993-05       Impact factor: 2.104

5.  Excessive fragmentary myoclonus in NREM sleep: a report of 38 cases.

Authors:  R Broughton; M A Tolentino; M Krelina
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1985-08

6.  Hypnic physiological myoclonias in man: an EEG-EMG study in normals and neurological patients.

Authors:  N Dagnino; C Loeb; G Massazza; G Sacco
Journal:  Eur Neurol       Date:  1969       Impact factor: 1.710

7.  Physiological hypnic myoclonus.

Authors:  P Montagna; R Liguori; M Zucconi; E Sforza; A Lugaresi; F Cirignotta; E Lugaresi
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1988-08

8.  Fragmentary pathological myoclonus in NREM sleep.

Authors:  R Broughton; M A Tolentino
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1984-04
  8 in total
  1 in total

1.  A 62-year-old Man with Facial and Finger Twitching.

Authors:  Stuart J McCarter; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.